Artemis Medicare Services Limi

Artemis Medicare Services Limi

ARTEMISMED.BO
Artemis Medicare Services LimiIN flagBombay Stock Exchange
268.00
INR
+4.70
- -
42.36BMarket Cap
Artemis Medicare Services Limi
ARTEMISMED.BO
(Bombay Stock Exchange)

Recent

price

268.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Artemis Medicare Services Limited (ARTEMISMED.BO), established in 2007 and promoted by the Apollo Tyres Group, operates as a leading multi-specialty healthcare provider headquartered in Gurugram, Haryana, India; the company manages a flagship 541-bed quaternary care super-specialty hospital in Gurugram, JCI- and NABH-accredited, along with asset-light facilities under the Artemis Lite and Daffodils by Artemis brands totaling approximately 713 beds primarily in the Delhi-NCR region, with additional operations in Jaipur, South Delhi, New Gurugram, and Mauritius. It offers comprehensive inpatient and outpatient services across more than 40 specialties and 12 centres of excellence, including cardiology, oncology, neurology, orthopaedics, gastroenterology, nephrology, internal medicine, urology, ophthalmology, radiology, dental care, pain management, critical care, transplants, robotic surgery, and advanced procedures such as M6 CyberKnife radiation therapy, da Vinci robotic systems, CAR T-cell therapy, TAVI, and bone marrow transplants; the network serves corporate clients, international patients, government empanelments, and third-party administrators with executive health checks, emergency services, and specialized clinics for oncology, breast care, pain, obesity, stroke, and spine surgery. In recent developments, Artemis Medicare Services secured INR 330 crore investment from the International Finance Corporation (IFC) in 2024 via compulsorily convertible debentures, which the company converted into 1.89 crore equity shares in November 2025 to fund brownfield expansions adding around 200 beds at the flagship Gurugram hospital, greenfield projects in Tier II and III cities including cardiac care centres, new specialty services, and overall bed capacity growth toward 1,600 operational beds by FY26.